Preparation and purification of an end to end coupled mEGF-dextran conjugate

被引:8
作者
Zhao, QH
Gottschalk, I
Carlsson, J
Arvidsson, LE
Oscarsson, S
Medin, A
Ersson, B
Janson, JC
机构
[1] PHARMACIA BIOTECH AB, S-75182 UPPSALA, SWEDEN
[2] MALARDALEN UNIV, DEPT CHEM ENGN, S-63105 ESKILSTUNA, SWEDEN
[3] UPPSALA BIOMED CTR, BIOCHEM SEPARAT CTR, S-75123 UPPSALA, SWEDEN
关键词
D O I
10.1021/bc970173m
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The amino terminus of mouse epidermal growth factor (mEGF) was coupled directly to the aldehyde end of dextran through a reductive amination procedure. The highest coupling efficiency was similar to 80% and could be reached after similar to 24 h of reaction time at pH 8. Gel filtration on Sephadex G-50 Fine removed free mEGF from the conjugate. Preparative polyacrylamide gel electrophoresis was used to separate the conjugate from excess noncharged dextran. The conjugate bound specifically to the EGF receptor on cultured glioma cells as shown in displacement tests with free mEGF. The conjugate was stable in the pH interval 4-9, in 2 M sodium chloride, in 7 M urea, and in human serum and could still bind to the EGF receptor after such treatments. The conjugates are candidates for targeted nuclide therapy.
引用
收藏
页码:927 / 934
页数:8
相关论文
共 49 条
[1]   BINDING OF EPIDERMAL GROWTH FACTOR-DEXTRAN CONJUGATES TO CULTURED GLIOMA-CELLS [J].
ANDERSSON, A ;
HOLMBERG, A ;
CARLSSON, J ;
CARLSSON, J ;
PONTEN, J ;
WESTERMARK, B .
INTERNATIONAL JOURNAL OF CANCER, 1991, 47 (03) :439-444
[2]  
ANDERSSON A, 1992, J NEURO-ONCOL, V14, P213
[3]   GENE AMPLIFICATION IN MALIGNANT HUMAN GLIOMAS - CLINICAL AND HISTOPATHOLOGIC ASPECTS [J].
BIGNER, SH ;
BURGER, PC ;
WONG, AJ ;
WERNER, MH ;
HAMILTON, SR ;
MUHLBAIER, LH ;
VOGELSTEIN, B ;
BIGNER, DD .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1988, 47 (03) :191-205
[4]   ENHANCED STABILITY OF BETA-GALACTOSIDASE IN PARENCHYMAL AND NON-PARENCHYMAL LIVER-CELLS BY CONJUGATION WITH DEXTRAN [J].
BLOMHOFF, HK ;
BLOMHOFF, R ;
CHRISTENSEN, TB .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 757 (02) :202-208
[5]   CYANOHYDRIDOBORATE ANION AS A SELECTIVE REDUCING AGENT [J].
BORCH, RF ;
BERNSTEIN, MD ;
DURST, HD .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1971, 93 (12) :2897-+
[6]   STRATEGY FOR BORON NEUTRON-CAPTURE THERAPY AGAINST TUMOR-CELLS WITH OVER-EXPRESSION OF THE EPIDERMAL GROWTH FACTOR-RECEPTOR [J].
CARLSSON, J ;
GEDDA, L ;
GRONVIK, C ;
HARTMAN, T ;
LINDSTROM, A ;
LINDSTROM, P ;
LUNDQVIST, H ;
LOVQVIST, A ;
MALMQVIST, J ;
OLSSON, P ;
ESSAND, M ;
PONTEN, J ;
SJOBERG, S ;
WESTERMARK, B .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 30 (01) :105-115
[7]   EPIDERMAL GROWTH-FACTOR [J].
CARPENTER, G ;
COHEN, S .
ANNUAL REVIEW OF BIOCHEMISTRY, 1979, 48 :193-216
[8]   I125 LABELED HUMAN EPIDERMAL GROWTH-FACTOR - BINDING, INTERNALIZATION, AND DEGRADATION IN HUMAN FIBROBLASTS [J].
CARPENTER, G ;
COHEN, S .
JOURNAL OF CELL BIOLOGY, 1976, 71 (01) :159-171
[9]   RECEPTORS FOR EPIDERMAL GROWTH-FACTOR AND OTHER POLYPEPTIDE MITOGENS [J].
CARPENTER, G .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :881-914
[10]   DISTRIBUTION OF EPIDERMAL GROWTH-FACTOR BINDING-SITES IN THE ADULT-RAT LIVER [J].
CHABOT, JG ;
WALKER, P ;
PELLETIER, G .
AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 250 (06) :G760-G764